Pitkänen K, Haapajärvi T, Laiho M
Haartman Institute, Department of Virology, University of Helsinki, Finland.
Oncogene. 1998 Jan 29;16(4):459-69. doi: 10.1038/sj.onc.1201528.
Transcriptional activation and stabilization of p53 is a major response of mammalian cells to U.V.-light induced genetic damages, and possibly responsible for cell damage control. We have studied here by gel mobility shift and immunoblotting assays the activation and accumulation of p53 by U.V.C. and its dependency on cell cycle, protein synthesis and protein phosphorylation. In G0/G1 synchronized cells U.V.C.-induced p53 DNA-binding activity, but not its accumulation, whereas both events took place in G1/S and S-phase cells. The kinetics of p53 activation by U.V.C. were slow requiring at least 1 h and slowly increasing thereafter with full activation observed at 6 h. Treatment of cells with cycloheximide (CHX) prevented the activation of p53 in all phases of the cell cycle and its accumulation in G1/S and S. However, removing CHX-block allowed full activation and accumulation of p53 with fast kinetics even if 4 h had lapsed since the initial U.V.C. insult. This suggests that the protein synthesis-dependent signal initiating p53 activation by U.V.C. remains continuous in the cells. The requirement of protein phosphorylation as mediator of p53 activation by U.V.C. was studied by using chemical protein kinase inhibitors. Of the tested inhibitors, only staurosporine, a known inhibitor of protein kinase C (PKC) and various other kinases, inhibited both p53 activation and accumulation, whereas specific PKC inhibitors, tyrosine kinase inhibitors and a serine/threonine kinase inhibitor did not. PKC-mediation of the p53 U.V.-response was further ruled out by the reactivity of the activated p53 to C-terminal antibody PAb 421. Kinetic studies showed that staurosporine-mediated inhibition of p53 function is an early event in cell damage response. Thus dual, kinetically different events, de novo protein synthesis and staurosporine-inhibited protein phosphorylation are required for p53 activation and accumulation in all phases of the cell cycle. Notably, in the absence of U.V.-induced accumulation in G0/G1 cells, p53 activation is still subject to inhibition of protein synthesis.
p53的转录激活和稳定是哺乳动物细胞对紫外线诱导的基因损伤的主要反应,可能负责细胞损伤控制。我们在此通过凝胶迁移率变动分析和免疫印迹分析研究了紫外线C(UVC)对p53的激活和积累及其对细胞周期、蛋白质合成和蛋白质磷酸化的依赖性。在G0/G1期同步化的细胞中,UVC诱导了p53的DNA结合活性,但没有诱导其积累,而这两个事件在G1/S期和S期细胞中均发生。UVC激活p53的动力学过程缓慢,至少需要1小时,此后缓慢增加,在6小时时观察到完全激活。用放线菌酮(CHX)处理细胞可阻止p53在细胞周期的所有阶段被激活及其在G1/S期和S期的积累。然而,即使自最初的UVC损伤已经过去4小时,去除CHX阻断仍能使p53以快速动力学完全激活和积累。这表明在细胞中启动UVC诱导p53激活的蛋白质合成依赖性信号是持续存在的。通过使用化学蛋白激酶抑制剂研究了蛋白质磷酸化作为UVC激活p53的介质的必要性。在测试的抑制剂中,只有星形孢菌素(一种已知的蛋白激酶C(PKC)和各种其他激酶的抑制剂)抑制了p53的激活和积累,而特异性PKC抑制剂、酪氨酸激酶抑制剂和丝氨酸/苏氨酸激酶抑制剂则没有。活化的p53与C末端抗体PAb 421的反应性进一步排除了PKC介导p53的紫外线反应。动力学研究表明,星形孢菌素介导的对p53功能的抑制是细胞损伤反应中的早期事件。因此,在细胞周期的所有阶段,p53的激活和积累需要两种动力学不同的事件,即从头合成蛋白质和星形孢菌素抑制的蛋白质磷酸化。值得注意的是,在G0/G1期细胞中缺乏紫外线诱导的积累的情况下,p53的激活仍然受到蛋白质合成抑制的影响。